Brief: Vicore Q1 Operating Loss Widens To SEK 28.8 Million
May 5 (Reuters) - Vicore Pharma Holding AB VICOR.ST :
* Q1 OPERATING LOSS SEK 28.8 MILLION VERSUS LOSS SEK 16.1
MILLION
YEAR AGO
* COVID SITUATION MAY SLOW US DOWN A BIT, IT ALSO GENERATES
NEW
OPPORTUNITIES
Source text for Eikon: ID:nWkr31ndC4
Further company coverage: VICOR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Vicore Pharma Holding AB
See all newsBrief: Vicore Pharma Holding Q3 Net Revenues Amounted To Sek 0.6 Mln
Brief: Vicore Pharma Holding AB Phase 2B Aspire Trial Of Buloxibutid In Ipf Passes Pre-Planned Futility Analysis, On Track For Mid-2027 Topline Results
Brief: Vicore Pharma Q2 Operating Loss At SEK 150.1 Million
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:53 PM
Brief: Vicore Pharma Shares Start Trading In US On July 2